Table 1 Clinicopathological characteristics statistics of BLCA patients from TCGA
Clinicopathological characteristics | CDCA3 expression level | Total | P value | |
|---|---|---|---|---|
Low | High | |||
Overall | 211 | 165 | 376 | Â |
Gender | Â | Â | Â | |
 Female | 59 (27.96%) | 39 (23.64%) | 98 | 0.3430 |
 Male | 152 (72.04%) | 126 (76.36%) | 278 | |
Grade | Â | Â | Â | Â |
 Low | 17 (8.06%) | 3 (1.82%) | 20 | 0.0075** |
 High | 194 (91.94%) | 162 (98.18%) | 356 | |
Stage | Â | Â | Â | Â |
 I + II | 58 (27.49%) | 60 (36.36%) | 118 | 0.0657 |
 III + IV | 153 (72.51%) | 105 (63.64%) | 258 | |
T stage | Â | Â | Â | Â |
 T0 + T1 + T2 | 72 (34.12%) | 50 (30.30%) | 147 | 0.4324 |
 T3 + T4 | 139 (65.88%) | 115 (69.70%) | 229 | |
M stage | Â | Â | Â | Â |
 M0 | 110 (52.13%) | 70 (42.42%) | 180 | 0.0615 |
 M1 + MX | 101 (47.87%) | 95 (57.58%) | 196 | |
N stage | Â | Â | Â | Â |
 N0 | 128 (60.66%) | 96 (58.18%) | 224 | 0.6265 |
 N1 + N2 + NX | 83 (39.34%) | 69 (41.82%) | 152 | |